Jungle · 14 · Rare Holo · 1999
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium25 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $2,250 $200–$4,500 from sold comps | 51.9× | 39 | 0 |
| ▶PSA 9 | $150 $52.00–$400 | 3.5× | 590 | 39 |
| ▶PSA 8.5 | $53.23 | 1.2× | 15 | 629 |
| ▶PSA 8 | $69.90 $28.00–$200 | 1.6× | 1,176 | 644 |
| ▶PSA 7 | $59.91 $8.50–$130 from sold comps | 1.4× | 847 | 1,821 |
| ▶PSA 6 | $37.63 $15.00–$79.99 | 0.9× | 667 | 2,669 |
| ▶PSA 5 | $34.00 $13.50–$69.99 | 0.8× | 461 | 3,336 |
| ▶PSA 4 | $24.99 $15.99–$29.99 | 0.6× | 150 | 3,798 |
| ▶PSA 3 | $20.81 $13.00–$37.99 | 0.5× | 53 | 3,948 |
| ▶PSA 2 | $15.41 unverified | 0.4× | 24 | 4,001 |
| ▶PSA 1 | $164 unverified | 3.8× | 11 | 4,026 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9 | $66.42 | 1.5× | — | — |
| ▶BGS 8.5 | $23.99 unverified | 0.6× | — | — |
| ▶BGS 8 | $69.50 $26.52–$145 from sold comps | 1.6× | — | — |
| ▶BGS 7.5 | $11.25 unverified | 0.3× | — | — |
| ▶BGS 6 | $12.00 | 0.3× | — | — |
| ▶BGS 5.5 | $8.00 | 0.2× | — | — |
| ▶BGS 3 | $25.00 | 0.6× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $509 $225–$620 from sold comps | 11.7× | — | — |
| ▶CGC 9.5 | $62.77 unverified | 1.4× | — | — |
| ▶CGC 9 | $99.99 $56.20–$250 | 2.3× | — | — |
| ▶CGC 8.5 | $50.00 $35.00–$125 | 1.2× | — | — |
| ▶CGC 8 | $41.50 $35.00–$73.00 | 1.0× | — | — |
| ▶CGC 7.5 | $34.99 $25.00–$75.00 | 0.8× | — | — |
| ▶CGC 7 | $30.00 $24.99–$74.99 from sold comps | 0.7× | — | — |
| ▶CGC 6.5 | $46.00 $29.99–$64.99 from sold comps | 1.1× | — | — |
| ▶CGC 6 | $38.63 | 0.9× | — | — |
| ▶CGC 5.5 | $11.83 | 0.3× | — | — |
| ▶CGC 5 | $19.99 $16.50–$36.00 | 0.5× | — | — |
| ▶CGC 4 | $12.29 | 0.3× | — | — |
A model's opinion, not investment advice.